Targeting CDC7 improves sensitivity to chemotherapy of esophageal squamous cell carcinoma

被引:9
作者
Cao, Ji-Xiang [1 ,2 ]
Lu, Yao [3 ]
机构
[1] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China
[2] Xiamen Univ, Dept Pathol, Zhongshan Hosp, Xiamen 361004, Peoples R China
[3] Peking Univ, Hosp 3, Dept Rehabil Med, Beijing 100191, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2019年 / 12卷
基金
中国国家自然科学基金;
关键词
CDC7; ESCC; chemosensitivity; therapeutic target; proliferation; migration and invasion; THERAPEUTIC TARGET; CANCER; KINASE; CHEMORESISTANCE; REPLICATION; SURVIVAL; POTENT; FIBROBLASTS; ACTIVATION; RESISTANCE;
D O I
10.2147/OTT.S183629
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Purpose: The cell division cycle 7 (CDC7) is a serine/threonine kinase that is essential for DNA replication in human cells which has been identified to play a critical role in multiple cancer types. However, the expression and clinical significance of CDC7 in ESCC has never been reported. Patients and methods: CDC7 expression was detected in 30 ESCC and matched adjacent normal tissues, and a series of loss-of-function and gain-of-function assays were performed to evaluate the effects of CDC7 on the proliferation, migration and invasion, and chemoresistance of ESCC cells. Results: The results showed that CDC7 was highly expressed in ESCC tissues compared with matched adjacent normal tissues. Functional studies demonstrated that knockdown of CDC7 inhibited proliferation by arresting ESCC cells in the G0/G1 phase and inducing apoptosis. Knockdown of CDC7 also inhibited cell migration and invasion in ESCC cells. Furthermore, knockdown of CDC7 sensitized ESCC cells to Cis and 5-FU. Conclusion: Our results suggest that CDC7 is highly expressed in ESCC tissues, and silencing CDC7 enhances chemosensitivity of ESCC cells, providing a new avenue for ESCC therapy.
引用
收藏
页码:63 / 74
页数:12
相关论文
共 37 条
  • [1] [Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
  • [2] Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation
    Bonte, Dorine
    Lindvall, Charlotta
    Liu, Honyu
    Dykema, Karl
    Furge, Kyle
    Weinreich, Michael
    [J]. NEOPLASIA, 2008, 10 (09): : 920 - U31
  • [3] UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
    Chandrashekar, Darshan S.
    Bashel, Bhuwan
    Balasubramanya, Sai Akshaya Hodigere
    Creighton, Chad J.
    Ponce-Rodriguez, Israel
    Chakravarthi, Balabhadrapatruni V. S. K.
    Varambally, Sooryanarayana
    [J]. NEOPLASIA, 2017, 19 (08): : 649 - 658
  • [4] Cancer incidence and mortality in China, 2013
    Chen, Wanqing
    Zheng, Rongshou
    Zhang, Siwei
    Zeng, Hongmei
    Xia, Changfa
    Zuo, Tingting
    Yang, Zhixun
    Zou, Xiaonong
    He, Jie
    [J]. CANCER LETTERS, 2017, 401 : 63 - 71
  • [5] Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer
    Choschzick, Matthias
    Lebeau, Annette
    Marx, Andreas H.
    Tharun, Lars
    Terracciano, Luigi
    Heilenkoetter, Uwe
    Jaenicke, Fritz
    Bokemeyer, Carsten
    Simon, Ronald
    Sauter, Guido
    Schwarz, Joerg
    [J]. HUMAN PATHOLOGY, 2010, 41 (03) : 358 - 365
  • [6] p53 gain-of-function mutations increase Cdc7-dependent replication initiation
    Datta, Arindam
    Ghatak, Dishari
    Das, Sumit
    Banerjee, Taraswi
    Paul, Anindita
    Butti, Ramesh
    Gorain, Mahadeo
    Ghuwalewala, Sangeeta
    Roychowdhury, Anirban
    Alam, Sk Kayum
    Das, Pijush
    Chatterjee, Raghunath
    Dasgupta, Maitrayee
    Panda, Chinmay Kumar
    Kundu, Gopal C.
    Roychoudhury, Susanta
    [J]. EMBO REPORTS, 2017, 18 (11) : 2030 - 2050
  • [7] ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7
    Im, Jun-Sub
    Lee, Joon-Kyu
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (37) : 25171 - 25177
  • [8] Jaafari-Ashkavandi Z, 2017, BRAZ J OTORHINOLARYN
  • [9] Discovery of XL413, a potent and selective CDC7 inhibitor
    Koltun, Elena S.
    Tsuhako, Amy Lew
    Brown, David S.
    Aay, Naing
    Arcalas, Arlyn
    Chan, Vicky
    Du, Hongwang
    Engst, Stefan
    Ferguson, Kim
    Franzini, Maurizio
    Galan, Adam
    Holst, Charles R.
    Huang, Ping
    Kane, Brian
    Kim, Moon H.
    Li, Jia
    Markby, David
    Mohan, Manisha
    Noson, Kevin
    Plonowski, Arthur
    Richards, Steven J.
    Robertson, Scott
    Shaw, Kenneth
    Stott, Gordon
    Stout, Thomas J.
    Young, Jenny
    Yu, Peiwen
    Zaharia, Cristiana A.
    Zhang, Wentao
    Zhou, Peiwen
    Nuss, John M.
    Xu, Wei
    Kearney, Patrick C.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (11) : 3727 - 3731
  • [10] Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma
    Kulkarni, Anjana A.
    Kingsbury, Sarah R.
    Tudzarova, Slavica
    Hong, Hye-Kyung
    Loddo, Marco
    Rashid, Mohammed
    Rodriguez-Acebes, Sara
    Prevost, Andrew T.
    Ledermann, Jonathan A.
    Stoeber, Kai
    Williams, Gareth H.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2417 - 2425